EMEA-003273-PIP02-22
Submitted by Anonymous (not verified) on 21 May 2024 - 16:00
EMEA-003273-PIP02-22
EMEA-003090-PIP02-22
Submitted by Anonymous (not verified) on 21 May 2024 - 15:55
EMEA-003090-PIP02-22
EMEA-003355-PIP01-22
Submitted by Anonymous (not verified) on 21 May 2024 - 15:55
EMEA-003355-PIP01-22
EMEA-002247-PIP03-17-M01
Submitted by Anonymous (not verified) on 21 May 2024 - 15:53
EMEA-002247-PIP03-17-M01
EMA confirms recommendation for non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Submitted by Anonymous (not verified) on 21 May 2024 - 13:38
EMA confirms recommendation for non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Medical devices: new guidance for industry and notified bodies
Submitted by Anonymous (not verified) on 21 May 2024 - 13:35
Medical devices: new guidance for industry and notified bodies
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Submitted by Anonymous (not verified) on 21 May 2024 - 13:28
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
Submitted by Anonymous (not verified) on 21 May 2024 - 13:27
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
CTIS newsflash - 17 May 2024
Submitted by Anonymous (not verified) on 21 May 2024 - 12:18
CTIS newsflash - 17 May 2024
Agenda of the CVMP meeting 21-23 May 2024
Submitted by Anonymous (not verified) on 21 May 2024 - 9:05
Agenda of the CVMP meeting 21-23 May 2024